Metoprolol Tartrate Metoprolol Tartrate 50 MG Oral Tablet
INDICATIONS AND USAGE Hypertension Metoprolol tartrate tablets, USP are indicated for the treatment of Hypertension. They may be used alone or in combination with other antihypertensive agents. Angina Pectoris Metoprolol tartrate tablets, USP are indicated in the long-term treatment of Angina Pectoris. Myocardial Infarction Metoprolol tartrate tablets, USP are indicated in the treatment of hemodynamically stable patients with definite or suspected acute Myocardial Infarction to reduce cardiovascular mortality. Treatment with intravenous metoprolol can be initiated as soon as the patient's clinical condition allows (see DOSAGE AND ADMINISTRATION , CONTRAINDICATIONS , and WARNINGS ). Alternatively, treatment can begin within 3 to 10 days of the acute event (see DOSAGE AND ADMINISTRATION ).
Greenstone LLC
ROUND PINK C 74
C 74 ROUND PINK
Related Pills
Metoprolol Tartrate Metoprolol Tartrate 50 MG Oral Tablet
Greenstone LLC
metoprolol tartrate tablet film coated
acetris health, llc
glipizide tablet film coated extended release
par pharmaceutical, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Metoprolol Tartrate Tablets, USP are available as follows: Tablets 25 mg are white round shaped, film coated tablets debossed with ‘C over 73’ on one side and deep break line on other side. Bottles of 100 NDC 59762-1300-1 (Child Resistant Closure) Bottles of 1000 NDC 59762-1300-3 (Non Child Resistant Closure) Tablets 50 mg are pink round shaped, film coated tablets debossed with ‘C over 74’ on one side and deep break line on other side. Bottles of 100 NDC 59762-1301-1 (Child Resistant Closure) Bottles of 1000 NDC 59762-1301-3 (Non Child Resistant Closure) Tablets 100 mg are light blue round shaped, film coated tablets debossed with ‘C over 75’ on one side and deep break line on other side. Bottles of 100 NDC 59762-1302-1 (Child Resistant Closure) Bottles of 1000 NDC 59762-1302-3 (Non Child Resistant Closure) Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. To report SUSPECTED ADVERSE REACTIONS, contact greenstone LLC at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch greenSTONE® BRAND Distributed by: greenstone LLC Peacpack, NJ 07977 Code No.: DRUGS/AP/19/1993 Revised: 02/2013
More pills like ROUND C 74